Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotherapy-induced nausea and vomiting.

× No keyword cloud information.

237 in total

1. Impact on daily functioning and indirect/direct costs associated with chemotherapy-induced nausea and vomiting (CINV) in a U.S. population.

Authors: Amin Haiderali; Laura Menditto; Margaret Good; April Teitelbaum; Jessica Wegner
Journal: Support Care Cancer Date: 2010-06-09 Impact factor: 3.603

2. SEOM clinical guidelines for the treatment of antiemetic prophylaxis in cancer patients receiving chemotherapy.

Authors: Jesús García Gómez; M Eva Pérez López; Jesús García Mata; Dolores Isla Casado
Journal: Clin Transl Oncol Date: 2010-11 Impact factor: 3.405

3. Guidelines for the control of nausea and vomiting with chemotherapy of low or minimal emetic potential.

Authors: Ian Olver; Rebecca A Clark-Snow; Enzo Ballatori; Birgitte T Espersen; Emilio Bria; Karin Jordan
Journal: Support Care Cancer Date: 2010-08-29 Impact factor: 3.603

4. The antiemetic 5-HT3 receptor antagonist Palonosetron inhibits substance P-mediated responses in vitro and in vivo.

Authors: Camilo Rojas; Ying Li; Jie Zhang; Marigo Stathis; Jesse Alt; Ajit G Thomas; Sergio Cantoreggi; Silvia Sebastiani; Claudio Pietra; Barbara S Slusher
Journal: J Pharmacol Exp Ther Date: 2010-08-19 Impact factor: 4.030

5. Interaction between serotonin reuptake inhibitors, 5-HT3 antagonists, and NK1 antagonists in cancer patients receiving highly emetogenic chemotherapy: a case-control study.

Authors: Olivier Mir; Jean-Philippe Durand; Pascaline Boudou-Rouquette; Julie Giroux; Romain Coriat; Anatole Cessot; Stanislas Ropert; François Goldwasser; Raphaël Gaillard
Journal: Support Care Cancer Date: 2012-05-30 Impact factor: 3.603

6. Netupitant/Palonosetron.

Authors: Dennis J Cada; James Leonard; Danial E Baker
Journal: Hosp Pharm Date: 2015-04-08

7. Absorption, metabolism, and excretion of the antiemetic rolapitant, a selective neurokinin-1 receptor antagonist, in healthy male subjects.

Authors: Zhi-Yi Zhang; Jing Wang; Vikram Kansra; Xiaodong Wang
Journal: Invest New Drugs Date: 2018-07-21 Impact factor: 3.850

8. Resource Utilization for Chemotherapy-Induced Nausea and Vomiting Events in Patients with Solid Tumors Treated with Antiemetic Regimens.

Authors: Lee Schwartzberg; Brooke Harrow; Lincy S Lal; Janna Radtchenko; Gary H Lyman
Journal: Am Health Drug Benefits Date: 2015 Jul-Aug

9. Palonosetron exhibits higher total control rate compared to first-generation serotonin antagonists and improves appetite in delayed-phase chemotherapy-induced nausea and vomiting.

Authors: Hiroki Ueda; Chigusa Shimono; Tomoyasu Nishimura; Megumi Shimamoto; Hiroki Yamaue
Journal: Mol Clin Oncol Date: 2014-02-20

10. Delineation of vagal emetic pathways: intragastric copper sulfate-induced emesis and viral tract tracing in musk shrews.

Authors: Charles C Horn; Kelly Meyers; Audrey Lim; Matthew Dye; Diana Pak; Linda Rinaman; Bill J Yates
Journal: Am J Physiol Regul Integr Comp Physiol Date: 2014-01-15 Impact factor: 3.619